Literature DB >> 18830101

Detection of hypervascular hepatocellular carcinoma with multidetector-row CT: single arterial-phase imaging with computer-assisted automatic bolus-tracking technique compared with double arterial-phase imaging.

Takatoshi Kitamura1, Tomoaki Ichikawa, Sukru Mehmet Erturk, Hiroto Nakajima, Hironobu Sou, Tsutomu Araki, Shunichi Okada, Nobuyuki Enomoto.   

Abstract

PURPOSE: To compare single arterial-phase (SAP) computed tomography (CT) imaging with bolus tracking (BT) with double arterial-phase (DAP) CT imaging for detecting hypervascular hepatocellular carcinoma.
MATERIALS AND METHODS: The DAP images were obtained at 25 (DAP-early) and 40 seconds (DAP-late) after the start of contrast material injection. All patients underwent SAP-BT imaging where images were obtained 10 seconds after the CT attenuation value of the aorta reached the threshold value of 120 Hounsfield unit (HU) in 29 (group 120-HU), 160 HU in 30 (group 160-HU), and 200 HU in 32 patients (group 200-HU). Attenuation conspicuity with SAP-BT technique was compared with that with DAP technique using repeated-measures analysis of variance. Attenuation conspicuity and mean scan delays with SAP-BT images obtained with different threshold values were compared using analysis of variance. The sensitivities were compared using McNemar and Fisher exact tests.
RESULTS: Within all groups, mean attenuation conspicuity with SAP-BT and DAP-late was significantly higher than that with DAP-early. Regarding SAP-BT, mean attenuation conspicuity in group 200-HU (42 +/- 18 HU) was significantly higher than those in groups 120-HU (23 +/- 11 HU) and 160-HU (25 +/- 11 HU). Mean scan delays for SAP-BT were 24.2 seconds in group-120 HU, 26.8 seconds in group-160 HU, and 31.1 seconds in group-200 HU (P < 0.001). The mean sensitivity with SAP-BT technique in group 200-HU (92.7%) was significantly higher than those in groups 120-HU (72.4%) and 160-HU (71.1%).
CONCLUSIONS: Single arterial-phase CT scanning with bolus tracking can be effectively used to detect hepatocellular carcinoma when a threshold value of 200 HU is used.

Entities:  

Mesh:

Year:  2008        PMID: 18830101     DOI: 10.1097/RCT.0b013e318154b1f5

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

2.  Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model.

Authors:  Kazuhiro Murotani; Nobuyuki Kawai; Morio Sato; Hiroki Minamiguchi; Motoki Nakai; Tetsuo Sonomura; Seiki Hosokawa; Tadayoshi Nishioku
Journal:  Radiol Phys Technol       Date:  2012-08-08

3.  Dual-time points (18)F-FDG PET/CT imaging in detection of bone metastases from hepatocellular carcinoma.

Authors:  Xueren Zhao; Alex Yi; George Ariza; Lee Salcido
Journal:  Int J Clin Exp Med       Date:  2013-01-26

4.  Automatic bolus tracking versus fixed time-delay technique in biphasic multidetector computed tomography of the abdomen.

Authors:  Atoosa Adibi; Ali Shahbazi
Journal:  Iran J Radiol       Date:  2014-01-30       Impact factor: 0.212

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.